1-20 of 22
Keywords: ERK1/2
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Journal Articles
J Cell Sci (2019) 132 (16): jcs230490.
Published: 27 August 2019
.... In line with this, CXCL2 overexpression attenuated proliferation, as well as differentiation, of osteoblasts in vitro . By contrast, CXCL2 downregulation promoted osteoblast expansion and differentiation. Mechanistically, CXCL2 inhibits the ERK1/2 (MAPK3/1) signaling pathway in osteoblasts. Activation...
Includes: Supplementary data
Journal Articles
Journal Articles
Journal Articles
Journal Articles
J Cell Sci (2013) 126 (5): 1199–1206.
Published: 1 March 2013
... ERK1/2. CALHM1 also triggered activation of MEK1/2, the upstream ERK1/2-activating kinases, and of RSK1/2/3 and MSK1, two downstream effectors of ERK1/2 signaling. CALHM1-mediated activation of ERK1/2 signaling was controlled by the small GTPase Ras. Pharmacological inhibition of CALHM1 permeability...
Journal Articles
J Cell Sci (2012) 125 (19): 4620–4629.
Published: 1 October 2012
... of CD23 attenuated AIMP1-induced TNF-α secretion and AIMP1 binding to THP-1 and PBMCs. We also observed that in THP-1 and PBMCs, AIMP1-induced TNF-α secretion, mediated by CD23, involved activation of ERK1/2. Interestingly, endothelial monocyte activating polypeptide II (EMAP II), the C-terminal fragment...
Journal Articles
J Cell Sci (2012) 125 (18): 4264–4277.
Published: 15 September 2012
... migration. Using a combination of pharmacological inhibition and gene silencing approaches, we found that UTP activates the P2Y2 purinergic receptor and Gαq protein to inhibit EGF/ERK1/2-induced cell migration in keratinocytes. Using a keratinocyte cell line expressing an inducible form of the Raf kinase...
Includes: Supplementary data
Journal Articles
J Cell Sci (2012) 125 (14): 3320–3332.
Published: 15 July 2012
... upregulation of ARNT showed the opposite. In ARNT-deficient monolayer cultures and 3D epidermal equivalents, the downregulation of AREG was concurrent with a decline of EGFR and ERK1/2 phosphorylation. TSA, a potent suppressor of HDAC activity, abolished the effects of ARNT deficiency, implying a role...
Includes: Supplementary data
Journal Articles
Journal Articles
J Cell Sci (2011) 124 (7): 1043–1054.
Published: 1 April 2011
..., which are considered hallmarks of nitric oxide (NO) toxicity. In neuroblastoma cells, BSO treatment also induces cell proliferation arrest through the ERK1/2-p53 pathway that finally results in caspase-independent apoptosis, as evident from the translocation of apoptosis-inducing factor from...
Includes: Supplementary data
Journal Articles
In collection:
Proteostasis
J Cell Sci (2011) 124 (6): 969–977.
Published: 15 March 2011
...Ceri M. Wiggins; Peter Tsvetkov; Mark Johnson; Claire L. Joyce; Christopher A. Lamb; Nia J. Bryant; David Komander; Yosef Shaul; Simon J. Cook BIM-extra long (BIM EL ), a pro-apoptotic BH3-only protein and part of the BCL-2 family, is degraded by the proteasome following activation of the ERK1/2...
Includes: Supplementary data
Journal Articles
Journal Articles
Journal Articles
J Cell Sci (2008) 121 (22): 3729–3736.
Published: 15 November 2008
...-type macrophages. ERK1/2 activity was reduced in PAK1 –/– macrophages during adhesion, and inhibition of ERK1/2 activation in wild-type macrophages was sufficient to increase the spread area and mimic the lamellipodial dynamics of PAK1 –/– macrophages. Together, these data indicate that PAK1 signals...
Includes: Multimedia, Supplementary data
Journal Articles
J Cell Sci (2008) 121 (13): 2197–2207.
Published: 1 July 2008
...-terminus, localization of Smad to the nucleus as well as Smad-driven promoter activity exclusively in oral keratinocytes but not in OSCC cells. The effect of EGF on TGFβ1-mediated Smad-driven promoter activity and N-cadherin expression was reversed when activation of ERK1/2 was blocked. Although EGF...
Journal Articles
Journal Articles
Journal Articles